Skip to Main Content

Roche announced Monday that Bill Anderson, CEO of its pharmaceuticals division, will step down after nearly four years at the helm.

His last day will be Dec. 31, Roche said, as Anderson leaves to “pursue opportunities outside of Roche.” A successor will be appointed by March, the company added. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment